| CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients | |
| Yang, Lin; Zou, Shanshan; Shu, Chang; Song, Yan; Sun, Yong-Kun; Zhang, Wen; Zhou, Aiping; Yuan, Xinghua; Yang, Yi; Hu, Songnian | |
| 2017 | |
| 卷号 | 15期号:4页码:255-262 |
| 关键词 | CYP2A6 Gastric cancer Pharmacogenomics Polymorphism SOX |
| ISSN号 | 1672-0229 |
| DOI | 10.1016/j.gpb.2016.11.004 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED ; CSCD |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6363490 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Yang, Lin,Zou, Shanshan,Shu, Chang,et al. CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients[J],2017,15(4):255-262. |
| APA | Yang, Lin.,Zou, Shanshan.,Shu, Chang.,Song, Yan.,Sun, Yong-Kun.,...&Hu, Songnian.(2017).CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients.,15(4),255-262. |
| MLA | Yang, Lin,et al."CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients".15.4(2017):255-262. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论